AnalystsCorinne JohnsonCorinne Johnson's Stock Forecasts
AnalystsCorinne Johnson
Sectors:
Analyst Ranking
Top 37%
#1815 out of 4995 analysts
Average Return
+7.87%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
Corinne Johnson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Syndax Pharmaceuticals IncSNDX | +65.38% | $9.82 | $16.24 | 2025-07-09 - 2025-08-22 | Strong Buy |
Avidity Biosciences IncRNA | +47.28% | $31.47 | $46.35 | 2025-07-09 - 2025-08-22 | Strong Buy |
Arrivent Biopharma IncAVBP | +31.41% | $20.63 | $27.11 | 2024-02-19 - 2025-02-19 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +25.85% | $7.39 | $9.30 | 2025-07-09 - 2025-08-22 | Strong Buy |
Avidity Biosciences IncRNA | +5.34% | $44.00 | $46.35 | 2024-09-23 - 2025-08-22 | Strong Buy |
Corinne Johnson Analyst Color
Get additional color on Corinne Johnson's coverage of popular stocks
Corinne Johnson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avidity Biosciences IncRNA | 2 | Strong Buy | $55.00 | +18.66% | Reinstates | a month ago |
Arrivent Biopharma IncAVBP | 3 | Strong Buy | $33.00 | +64.10% | Reinstates | a month ago |
Amylyx Pharmaceuticals IncAMLX | 1 | Strong Buy | $10.00 | +7.53% | Reinstates | a month ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $18.00 | +10.84% | Initiates Coverage On | a month ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $182.00 | +34.39% | Initiates Coverage On | a month ago |
Cg Oncology IncCGON | 3 | Strong Buy | $50.00 | N/A | Upgrades | a year ago |
Immunovant IncIMVT | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.